Company intelligence / Profile preview

COEUS

Ownership: Private
Employees: ~140
Development stage: Commercial

Overview

COEUS is a leading US-headquartered healthcare consultancy specializing in market access strategy, including pricing, reimbursement analytics, and HEOR for pharmaceutical manufacturers. It focuses particularly on innovative modalities like cell and gene therapies and rare diseases. The company does not develop therapeutics but provides critical commercial support services across the product lifecycle for life sciences organizations. It was acquired by Red Nucleus in early 2025 but continues operations under its established brand.

Industry: Consulting

Partnerships

Emerging Therapy Solutions (for value-based healthcare innovation)

Beyond the preview

Go deeper on COEUS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on COEUS.

Explore the full profile